In this article, we are going to take a look at where Geron Corporation (NASDAQ:GERN) stands against other best stocks to penny stocks that will skyrocket. Is It a Good Time to Diversify Your ...

Geron (NASDAQ: GERN) stock is getting crushed in Wednesday's trading. The company's share price was down 31.7% as of 3:50 p.m. ET and had been down as much as 38.7% earlier in the session.

Reports Q4 revenue $47.54M, consensus $45.29M. “2024 was a terrific year for Geron (GERN) and for RYTELO, our first-in-class telomerase inhibitor, which we believe represents a highly ...

Geron shares fell 30% to $1.66 after the company reported a fourth-quarter loss that was wider than expected. The biopharmaceutical company had a quarterly loss of $25.4 million, or 4 cents a ...

Geron stock is seeing a dramatic pullback following the company's fourth-quarter report. Geron's earnings in Q4 fell short of Wall Street's expectations, and management had worrying guidance for ...